B-Cell Maturation Antigen (BCMA) Targeted Therapies Report

By www.regionalmarketresearch.com

 Request Sample Report

Report Details

Report Name

Global And United States B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Report & Forecast 2024-2031 Story

Pages

104

Price

$ 4350

 Request Sample Report

Features

B-Cell Maturation Antigen (BCMA) Targeted Therapies Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

 Request Sample Report

Companies Covered

              Transposagen Biopharmaceuticals
Sutro Biopharma
Malin Corporation
Eureka Therapeutics
firstVentury Equity
Five Prime Therapeutics
Credit Suisse Securities
Dana-Farber Cancer Institute
Deerfield Partners
Onyx Pharmaceuticals
Juno Therapeutics
Request Sample Report